What's New/

Submissions

ellipse bg 3

Our submissions

Migraine Foundation Aotearoa New Zealand actively engages with organisations to advocate for the advancement of migraine care, treatment and research in Aotearoa.

Response to Pharmac’s proposed declining of inactive application for zolmitriptan

7 February 2024

Presentation to the Neurological Advisory Committee meeting (Pharmac)

19 September 2023

Feedback to Pharmac on the Pharmacology and Therapeutics Advisory Committee (PTAC) review of erenumab application on 18 August 2022

December 2022

Application to the Ministry of Health to add questions about migraine to the New Zealand Health Survey

June 2022

Feedback to the Pharmacology and Therapeutics Advisory Committee (PTAC) on their decision regarding funding of erenumab

April 2022